Rosa Ruchlemer

1.9k total citations
48 papers, 733 citations indexed

About

Rosa Ruchlemer is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Rosa Ruchlemer has authored 48 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 25 papers in Pathology and Forensic Medicine and 11 papers in Hematology. Recurrent topics in Rosa Ruchlemer's work include Chronic Lymphocytic Leukemia Research (31 papers), Lymphoma Diagnosis and Treatment (23 papers) and Immunodeficiency and Autoimmune Disorders (10 papers). Rosa Ruchlemer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (31 papers), Lymphoma Diagnosis and Treatment (23 papers) and Immunodeficiency and Autoimmune Disorders (10 papers). Rosa Ruchlemer collaborates with scholars based in Israel, United States and United Kingdom. Rosa Ruchlemer's co-authors include Aaron Polliack, Osnat Bairey, Lev Shvidel, E Matutes, Sorina Grisaru‐Granovsky, Arnon Samueloff, Tamar Tadmor, Karen Agnew, Lior Drukker and Yael Hants and has published in prestigious journals such as Blood, Cancer and The American Journal of Medicine.

In The Last Decade

Rosa Ruchlemer

48 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Ruchlemer Israel 14 360 297 167 139 139 48 733
T. Economopoulos Greece 15 61 0.2× 203 0.7× 80 0.5× 294 2.1× 74 0.5× 32 694
Nicola Piccirillo Italy 14 184 0.5× 94 0.3× 330 2.0× 176 1.3× 145 1.0× 67 715
Jordi Juncà Spain 13 205 0.6× 177 0.6× 242 1.4× 192 1.4× 194 1.4× 83 742
Aarthi Shenoy United States 13 104 0.3× 84 0.3× 327 2.0× 189 1.4× 117 0.8× 41 649
Gita Massey United States 14 162 0.5× 68 0.2× 678 4.1× 79 0.6× 87 0.6× 40 1.1k
J. Jackson Ireland 14 258 0.7× 132 0.4× 443 2.7× 77 0.6× 133 1.0× 28 930
J Kerbauy Brazil 14 334 0.9× 74 0.2× 468 2.8× 68 0.5× 61 0.4× 55 700
Jane Mercieca United Kingdom 10 322 0.9× 215 0.7× 467 2.8× 215 1.5× 272 2.0× 14 835
Alba Erra Spain 15 110 0.3× 123 0.4× 111 0.7× 87 0.6× 160 1.2× 25 759
Tomohiro Kameda Japan 14 107 0.3× 121 0.4× 40 0.2× 77 0.6× 92 0.7× 64 547

Countries citing papers authored by Rosa Ruchlemer

Since Specialization
Citations

This map shows the geographic impact of Rosa Ruchlemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Ruchlemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Ruchlemer more than expected).

Fields of papers citing papers by Rosa Ruchlemer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Ruchlemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Ruchlemer. The network helps show where Rosa Ruchlemer may publish in the future.

Co-authorship network of co-authors of Rosa Ruchlemer

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Ruchlemer. A scholar is included among the top collaborators of Rosa Ruchlemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Ruchlemer. Rosa Ruchlemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ruchlemer, Rosa, et al.. (2021). Incidence, risk factors, and recognition of pseudohyperkalemia in patients with chronic lymphocytic leukemia. International Journal of Hematology. 114(1). 102–108. 4 indexed citations
2.
Ruchlemer, Rosa, et al.. (2019). Pseudohyperkalemia in Chronic Lymphocytic Leukemia. The American Journal of Medicine. 133(2). e52–e53. 2 indexed citations
3.
Joffe, Erel, Neta Goldschmidt, Osnat Bairey, et al.. (2018). Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials. European Journal Of Haematology. 101(3). 399–406. 5 indexed citations
4.
Herishanu, Yair, Neta Goldschmidt, Osnat Bairey, et al.. (2018). Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel. Anticancer Research. 38(11). 6423–6429. 8 indexed citations
5.
Joffe, Erel, Osnat Bairey, Riva Fineman, et al.. (2017). Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival. Hematological Oncology. 36(1). 128–135. 3 indexed citations
6.
Dann, Eldad J., Osnat Bairey, Rachel Bar‐Shalom, et al.. (2017). Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients. British Journal of Haematology. 178(5). 709–718. 26 indexed citations
7.
Ruchlemer, Rosa, et al.. (2014). Inhaled medicinal cannabis and the immunocompromised patient. Supportive Care in Cancer. 23(3). 819–822. 40 indexed citations
8.
9.
Ruchlemer, Rosa, Neta Goldschmidt, Moshe Levin, et al.. (2014). Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia. Leukemia & lymphoma. 55(11). 2525–2531. 28 indexed citations
10.
Tadmor, Tamar, Lev Shvidel, Ariel Aviv, et al.. (2013). Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis. Cancer. 119(10). 1853–1859. 11 indexed citations
11.
Ruchlemer, Rosa & Aaron Polliack. (2012). Geography, ethnicity and “roots” in chronic lymphocytic leukemia. Leukemia & lymphoma. 54(6). 1142–1150. 30 indexed citations
12.
Ruchlemer, Rosa, et al.. (2011). Gaucher Disease and LGL Proliferations: Provocative Commonality?. Blood. 118(21). 1100–1100. 1 indexed citations
13.
Bairey, Osnat, Ohad Benjamini, Dorit Blickstein, Avishay Elis, & Rosa Ruchlemer. (2006). Non-Hodgkin's lymphoma in patients 80 years of age or older. Annals of Oncology. 17(6). 928–934. 42 indexed citations
14.
Nemets, Anatoly, et al.. (2005). Osteomyelitis of the Jaw in Multiple Myeloma Patients as a Complication of the Treatment with Biphosphonates.. Blood. 106(11). 5141–5141. 1 indexed citations
15.
Agnew, Karen, Rosa Ruchlemer, Daniel Catovsky, E Matutes, & Clareann H. Bunker. (2004). Cutaneous findings in chronic lymphocytic leukaemia. British Journal of Dermatology. 150(6). 1129–1135. 98 indexed citations
16.
Fisher, D., et al.. (1997). Aggressive bone destruction in acute megakaryocytic leukemia: a rare presentation. Pediatric Radiology. 27(1). 20–22. 13 indexed citations
17.
Ruchlemer, Rosa, et al.. (1996). Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.. PubMed. 32(11). 1089–92. 10 indexed citations
18.
Kotler, Moshe, et al.. (1994). Radiation leukemogenesis: Quantitative relationship between pre‐leukemic cells in the thymus and lymphoma induction. International Journal of Cancer. 56(5). 761–765. 3 indexed citations
19.
Marmary, Yitzhak, Gilles Lugassy, Rosa Ruchlemer, et al.. (1991). Primary Lymphoma of the Parotid Gland: A Report of Twelve Cases with a Review of the Literature. Leukemia & lymphoma. 5(2-3). 133–137. 3 indexed citations
20.
Engelhard, Dan, Abraham Morag, Gabriel Cividalli, et al.. (1988). Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.. PubMed. 24(3). 145–50. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Economopoulos Breakdown of academic impact, for papers by Nicola Piccirillo Breakdown of academic impact, for papers by Jordi Juncà Breakdown of academic impact, for papers by Aarthi Shenoy Breakdown of academic impact, for papers by Gita Massey Breakdown of academic impact, for papers by J. Jackson Breakdown of academic impact, for papers by J Kerbauy Breakdown of academic impact, for papers by Jane Mercieca Breakdown of academic impact, for papers by Alba Erra Breakdown of academic impact, for papers by Tomohiro Kameda
Rankless by CCL
2026